| Dr Kyle H Townsend, PHARMD, BCPS | |
|
2800 10th Ave N, Billings, MT 59101-0703 | |
| (406) 657-4213 | |
| Not Available |
| Full Name | Dr Kyle H Townsend |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacotherapy |
| Location | 2800 10th Ave N, Billings, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467454207 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P1200X | Pharmacist - Pharmacotherapy | 3015 (Wyoming) | Secondary |
| 1835P1200X | Pharmacist - Pharmacotherapy | 6339 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kyle H Townsend, PHARMD, BCPS 2800 10th Ave N, Billings, MT 59101-0703 Ph: (406) 657-4213 | Dr Kyle H Townsend, PHARMD, BCPS 2800 10th Ave N, Billings, MT 59101-0703 Ph: (406) 657-4213 |
News Archive
New research from the Prevention Research Center of the Pacific Institute for Research and Evaluation suggests that the impact of alcohol consumption on coronary heart disease may be underestimated.
Muscle Flex Inc. (www.MuscleFlex.com) announced today that it will be releasing simultaneously the Beagle StepFit™ (www.BuyTheBeagle.com) and the BUDDY Tablet Caddy™ (www.GetTheBUDDY.com) along with the national release of the Muscle Flex VATA Brasil Sports and Active Wear Collection.
Three Florida HMOs have said they will continue participating in a "Medicaid Reform" plan after the Agency for Health Care Administration agreed to reduce payments by an average of 3% on Sept. 1, instead of 5% as previously announced, Florida Health News reports (Florida Health News, 9/2).
NeoRx Corporation today announced that it has acquired from AnorMED Inc. the worldwide exclusive rights, excluding Japan, to develop, manufacture and commercialize AMD473, a platinum-based anti-cancer agent. AMD473 has been administered to more than 500 cancer patients in phase I and phase II clinical trials, demonstrating anti-cancer activity in a wide range of tumors and a manageable safety profile. NeoRx expects to initiate clinical studies of AMD473 in one or more cancer indications in the second half of this year.
› Verified 5 days ago
Hannah Elizabeth Johnson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1649 Main St, Billings, MT 59105 Phone: 406-254-2842 | |
David Sanks, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2525 King Ave W, Billings, MT 59102 Phone: 406-652-9688 | |
Joshua Teynor, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1602 Main St, Billings, MT 59105 Phone: 406-245-0178 | |
Gerald Robbin Fisher, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3333 Grand Ave, Billings, MT 59102 Phone: 406-652-1620 | |
Dr. Natalie Marie Waterfall, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 670 Main St, Billings, MT 59105 Phone: 406-245-6979 | |
Barbara Metzger, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2290 King Ave W, Billings, MT 59102 Phone: 406-656-8556 | |
Kailey Klinger, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1775 Spring Creek Lane, Billings, MT 59102 Phone: 406-373-3500 Fax: 406-373-3607 |